机译:通过YTTRIUM-90放射性栓塞治疗不可切除的肝内胆管癌患者总体存活的预后因素:治疗 - NAα患者的结果
Institute for Diagnostic and Interventional Radiology Klinikum Karlsruhe Academic Teaching;
Department of Diagnostic Radiology M D Anderson Cancer Center;
Medical Clinic III Department of Hematology Oncology Infectious Disease and Palliative Medicine;
Department of General and Visceral Surgery Klinikum Karlsruhe Academic Teaching Hospital of the;
Department of General and Visceral Surgery Klinikum Karlsruhe Academic Teaching Hospital of the;
Department of Nuclear Medicine Klinikum Karlsruhe Academic Teaching Hospital of the University of;
Overall survival; Yttrium-90 radioembolization; Intrahepatic cholangiocarcinoma; Tumor burden;
机译:矫正:通过YTTRIUM-90放射性栓塞治疗不可切除的肝内胆管癌患者整体存活的预后因素:治疗 - NAα患者的结果
机译:通过钇-90放射性栓塞治疗不可切除的肝内胆管癌患者整体存活的预后因素:治疗-NAα患者的结果
机译:不可切除的肝内胆管癌患者的经动脉肝钇90放射栓塞:与延长生存期相关的因素
机译:基质金属蛋白酶-2和高血管内皮生长因子作为肝细胞癌肝癌患者肝内肿瘤复发的预后标志物,接受放射治疗
机译:2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床,组织病理学和生物学参数的预后意义
机译:钇90放射栓塞治疗晚期肝内胆管癌总生存的预后因素
机译:矫正:通过YTTRIUM-90放射性栓塞治疗不可切除的肝内胆管癌患者整体存活的预后因素:治疗 - 诺芬患者的结果
机译:在过去OV-1012期间,患有Lennox Gastaut综合征的Clobazam治疗患者经历的癫痫发作相关损伤少于安慰剂患者。